Davis J. E.
CEO and President
Davis J. E. has filed 7 SEC Form 4 filings (14 transaction rows) across 1 company, with disclosures dating back to 2025. 7 of those filings fall inside the rolling window. Most recent filing: Sep 3, 2026.
On the most recent filing, Davis J. E. is listed as CEO and President at QUEST DIAGNOSTICS INC. Inside the rolling window, Davis J. E. reported no open-market purchases and 4 open-market sales totaling $17.1M in DGX. The largest disclosed transaction in the window is a sale of 55,093 DGX shares on Nov 25, 2025, worth $10.6M.
Companies traded
Other insiders at DGX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$17.1M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Davis J. E. made?
Davis J. E. has filed 7 SEC Form 4 filings (14 transaction rows) across 1 company since 2025.
Which companies does Davis J. E. trade?
Davis J. E. has filed SEC Form 4 disclosures for 1 company, including DGX.
When was Davis J. E.'s most recent SEC Form 4 filing?
Davis J. E.'s most recent SEC Form 4 filing on Tracefour is dated Sep 3, 2026.
What is Davis J. E.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Davis J. E. is listed as CEO and President.
What is Davis J. E.'s total buy and sell value in the current window?
Inside the rolling retention window, Davis J. E. bought $0 and sold $17.1M based on SEC Form 4 filings.
What was Davis J. E.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 55,093 DGX shares on 2025-11-25, worth $10.6M, per SEC Form 4 filings.